FOLH1 and posterior cortical atrophy: The recent emergence of 68Ga-labeled PSMA inhibitors as promising agents for positron emission tomography/computed tomography (PET/CT) in patients with primary PCa has demonstrated diagnostic and staging capabilities that are superior to conventional imaging techniques (9–11).